"I am comparing unmeth chemorad in the Stupp trial with unmeth chemorad in the DCVax trial. The only difference being is that DCVax trial data is still blended.
Apples to apples."
Stupp patients reflected the results of standard of care available in Canada in 2002. Stupp did not require "surgical resection with the intent for a gross or near total resection of the contrast-enhancing tumor mass." Stupp patients did not receive the benefit of over a decade of improvements in surgical technique and and radiological imaging and treatment.
"If you think the Stupp unmeth figures are 'clinically relevant' then you must surely think the DCVax figures are 230% more clinically relevant!"
If the "L" treatment arm shows a statistically significant improvement in PFS or OS as compared to the control arm, I will be impressed. That would be an "apples to apples" comparison.